Haiquan Huang1,2, Stacey E Jolly3, Medha Airy4, Susana Arrigain5, Jesse D Schold1,5, Joseph V Nally1, Sankar D Navaneethan4,6. 1. Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. 2. Department of Geriatrics, Zhongda Hospital affiliated with Southeast University, Nanjing, China. 3. Medicine Institute, Cleveland Clinic, Cleveland, OH, USA. 4. Section of Nephrology, Department of Medicine, Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, TX, USA. 5. Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. 6. Section of Nephrology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.
Abstract
BACKGROUND: Hyponatremia and hypernatremia are associated with death in the general population and those with chronic kidney disease (CKD). We studied the associations between dysnatremias, all-cause mortality and causes of death in a large cohort of Stage 3 and 4 CKD patients. METHODS: We included 45 333 patients with Stage 3 and 4 CKDs followed in a large healthcare system. Associations between hyponatremia (<136 mmol/L) and hypernatremia (>145), and all-cause mortality and causes of death (cardiovascular, malignancy related and non-cardiovascular/non-malignancy related) were studied using Cox proportional hazards and competing risk models. RESULTS: Dysnatremias were found in 9.2% of the study population. In separate multivariable Cox proportional hazards models using baseline serum sodium levels and time-dependent repeated measures, both hyponatremia and hypernatremia were associated with all-cause mortality. In the competing risk analyses, hyponatremia was significantly associated with increased risk for various cause-specific mortality categories [cardiovascular (hazard ratio, HR 1.16, 95% confidence interval, CI: 1.04, 1.30), malignancy related (HR 1.48, 95% CI: 1.33, 1.65) and non-cardiovascular/non-malignancy deaths (HR 1.25, 95% CI: 1.13, 1.39)], while hypernatremia was significantly associated with higher non-cardiovascular/non-malignancy mortality only (HR 1.36, 95% CI: 1.08, 1.72). CONCLUSIONS: In those with CKD, hyponatremia was associated with all-cause mortality, cardiovascular, malignancy and non-cardiovascular/non-malignancy-related deaths. Hypernatremia was associated with all-cause and non-cardiovascular/non-malignancy-related deaths. Further studies are needed to elucidate the mechanisms of differences in cause-specific death among CKD patients with hyponatremia and hypernatremia.
BACKGROUND: Hyponatremia and hypernatremia are associated with death in the general population and those with chronic kidney disease (CKD). We studied the associations between dysnatremias, all-cause mortality and causes of death in a large cohort of Stage 3 and 4 CKD patients. METHODS: We included 45 333 patients with Stage 3 and 4 CKDs followed in a large healthcare system. Associations between hyponatremia (<136 mmol/L) and hypernatremia (>145), and all-cause mortality and causes of death (cardiovascular, malignancy related and non-cardiovascular/non-malignancy related) were studied using Cox proportional hazards and competing risk models. RESULTS: Dysnatremias were found in 9.2% of the study population. In separate multivariable Cox proportional hazards models using baseline serum sodium levels and time-dependent repeated measures, both hyponatremia and hypernatremia were associated with all-cause mortality. In the competing risk analyses, hyponatremia was significantly associated with increased risk for various cause-specific mortality categories [cardiovascular (hazard ratio, HR 1.16, 95% confidence interval, CI: 1.04, 1.30), malignancy related (HR 1.48, 95% CI: 1.33, 1.65) and non-cardiovascular/non-malignancy deaths (HR 1.25, 95% CI: 1.13, 1.39)], while hypernatremia was significantly associated with higher non-cardiovascular/non-malignancy mortality only (HR 1.36, 95% CI: 1.08, 1.72). CONCLUSIONS: In those with CKD, hyponatremia was associated with all-cause mortality, cardiovascular, malignancy and non-cardiovascular/non-malignancy-related deaths. Hypernatremia was associated with all-cause and non-cardiovascular/non-malignancy-related deaths. Further studies are needed to elucidate the mechanisms of differences in cause-specific death among CKD patients with hyponatremia and hypernatremia.
Authors: Joji B Kuramatsu; Tobias Bobinger; Bastian Volbers; Dimitre Staykov; Hannes Lücking; Stephan P Kloska; Martin Köhrmann; Hagen B Huttner Journal: Stroke Date: 2014-04-08 Impact factor: 7.914
Authors: Sinead Kinsella; Sarah Moran; Miriam O Sullivan; Michael G M Molloy; Joseph A Eustace Journal: Clin J Am Soc Nephrol Date: 2010-01-07 Impact factor: 8.237
Authors: George Liamis; Eline M Rodenburg; Albert Hofman; Robert Zietse; Bruno H Stricker; Ewout J Hoorn Journal: Am J Med Date: 2013-01-18 Impact factor: 4.965
Authors: Connie M Rhee; Vanessa A Ravel; Juan Carlos Ayus; John J Sim; Elani Streja; Rajnish Mehrotra; Alpesh N Amin; Danh V Nguyen; Steven M Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh Journal: Nephrol Dial Transplant Date: 2015-09-25 Impact factor: 5.992
Authors: Paula F Orlandi; Dawei Xie; Wei Yang; Jordana B Cohen; Rajat Deo; Ana C Ricardo; Sarah Schrauben; Xue Wang; L Lee Hamm; Jiang He; James H Sondheimer; Krishna Kallem; Raymond Townsend; Dominic Raj; Afshin Parsa; Amanda H Anderson; Harold I Feldman Journal: J Am Soc Nephrol Date: 2020-10-06 Impact factor: 10.121
Authors: Nicholas I Cole; Rebecca J Suckling; Vipula Desilva; Feng J He; Graham A MacGregor; Pauline A Swift Journal: J Nephrol Date: 2018-10-16 Impact factor: 3.902